Views: 0 Author: Site Editor Publish Time: 2023-10-21 Origin: Site
From May 28 to 30, 2023, the 20th China International Laboratory Medicine and Blood Transfusion Equipment Reagent Expo (CACLP) and the 3rd China International IVD Upstream Raw Material Manufacturing and Circulation Supply Chain Expo (CISCE) were successfully held in Nanchang Greenland International Expo Center .
ZECEN Biotech showed a series of fully automatic chemiluminescence immunoassay products, and brought the chemiluminescence CDMO system solution to the audience, receiving high recognition from everyone..
Director Yan Guangtao, a researcher at the Laboratory Department of the General Hospital of the Chinese People's Liberation Army, visited the Zecheng Biological booth for guidance.
Extension activities:
On May 27, IDL of Sweden and ZECEN Biotech held a promotion meeting on tissue polypeptide specific antigen (TPS), an indicator of tumor cell proliferation activity, at the Grand Cloud International Hotel in Nanchang.
This indicator was exclusively authorized by Swedish IDL Company to Zecheng Biotechnology for development in China. It has clear clinical significance for the diagnosis and treatment of epithelial tumors and metastatic cancers such as breast cancer, prostate cancer, ovarian cancer, colorectal cancer, and lung cancer. Lou Jiatao, director of the Laboratory Medicine Center of the First People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, was invited to attend the conference and delivered a speech.
Tissue peptide-specific antigen TPS Product Launch Event with complete success
Exhibition review | Highlights of Zecen Biotech & Medlab Asia 2024
The 2024 ZECEN Biotech Product Promotion Conference Was Successfully Held at CACLP
Innovation for Health,Quality for Life—— Zecen Biotech Germany MEDICA Exhibition Review
Sysmex & ZECEN signed a strategic cooperation agreement on March 9,2023
Win-win cooperation, complementary advantages! In-depth cooperation between sysmex and ZECEN biotech